GENSCRIPT BIOTECH CORPORATION |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.04 HKD | -2.75% |
|
+0.84% | -39.38% |
| May. 15 | Legend Expects to Log Profit in 2026 | MT |
| May. 14 | Legend Biotech's Loss Narrows in Q1 as Revenue Surges | MT |
Evolution of the average Target Price on Genscript Biotech Corporation
Price target over the last 5 years
History of analyst recommendation changes
c2113be0cc46b23.zm4dayMwzDIgT02li4ygx9DnDt6LY1JvYdQtbxeUHls.j1tIBhJBpn1RIgXM0d3yqOCoNpjNOgccNeRFPyXxdDj3BCU7e0agS0MkeQ~b0484a0000def8228a462ad5838d0633
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
1.587
USD
Average target price
3.554
USD
Spread / Average Target
+123.99%
High Price Target
4.227
USD
Spread / Highest target
+166.37%
Low Price Target
2.051
USD
Spread / Lowest Target
+29.25%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
- Stock Market
- Equities
- 1548 Stock
- Consensus Genscript Biotech Corporation